MITOMYCIN-C 2mg Injection 10s

Frequently asked questions

• Onset of action

  The amount of time required for this medicine to show its action is not clinically established.

• Duration of Effect

  The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

• Thrombocytopenia

  The medicine is not recommended for use in patients with low platelet counts due to the increased risk of worsening of the patient’s condition.

• Allergy

  This medicine is not recommended for use if you have a known allergy to MITOMYCIN-C 2mg Injection 10s or any other active ingredients present along with the formulation.

• Coagulation disorders

  The medicine is not recommended for use in patients with coagulation disorders (conditions that affect the normal blood's clotting activities) due to the increased risk of worsening of the patient’s condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

• Use in children

  This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established. However, the doctor may prescribe this medicine in certain circumstances if the benefits outweigh the risk. All the risks and benefits should be discussed with the doctor before administering this medicine.

• Risk of infections

  Use of this medicine may weaken the immune system and may make you more vulnerable to infections. It is advised that you avoid coming in contact with people suffering from an infection while receiving this medicine.

• Liver diseases

  This medicine should be used with caution in patients with a history of liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of the liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases based on the clinical condition.

• Lung impairment

  This medicine should be used with extreme caution in patients with a compromised lung function due to the increased risk of lung toxicity. Close monitoring of lung function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Kidney diseases

  This medicine should be used with caution in patients with kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of the kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative might be required in some cases based on the clinical condition.

• Driving or operating machinery

  Use of this medicine may rarely cause dizziness or lack of energy in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any dizziness or lack of energy during or immediately after treatment with this medicine.

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• May cause sleepiness

• pubchem - Mitomycin C [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/mitomycin_C [cited 2/3/2021]. 2021